Literature DB >> 2250115

Temperature distributions during clinical scanned, focused ultrasound hyperthermia treatments.

K Hynynen1, D Shimm, D Anhalt, B Stea, H Sykes, J R Cassady, R B Roemer.   

Abstract

In this study a scanned focused ultrasound (SFUS) system was used to heat 66 tumours at various anatomical locations in 52 patients. A total of 160 treatments were given. On average, temperatures were measured in 14 or 15 locations in the scanned volume. The time-averaged temperatures over the 30 min treatment period in the best treatment of each tumour were 44.0 +/- 2.4 degrees C (mean +/- SD) and 39.6 +/- 1.5 degrees C at the location of the highest and lowest sensor, respectively. On average, 39% of the sensors were above 42.5 degrees C. When only the cases that were judged to be good candidates for the hyperthermia device were analysed, 64% of the sensors reached a temperature over 42.5 degrees C with the highest temperature achieved being 45.9 +/- 2.3 degrees C and the lowest 40.7 +/- 1.4 degrees C. Although the system tested has many technical limitations (for example, fixed frequency, beam geometry and power during the scan cycle), the results demonstrate that therapeutic temperatures can be achieved in many tumours. Significantly better temperatures are expected when all of the theoretical potential of scanned focused ultrasound systems has been used.

Entities:  

Mesh:

Year:  1990        PMID: 2250115     DOI: 10.3109/02656739009140971

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  2 in total

1.  An experimental high energy therapeutic ultrasound equipment: design and characterisation.

Authors:  T Kirkhorn; L O Almquist; H W Persson; N G Holmer
Journal:  Med Biol Eng Comput       Date:  1997-05       Impact factor: 2.602

Review 2.  High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology.

Authors:  G Malietzis; L Monzon; J Hand; H Wasan; E Leen; M Abel; A Muhammad; P Price; P Abel
Journal:  Br J Radiol       Date:  2013-02-12       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.